Credit Suisse’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.26M | Buy |
34,162
+7,520
| +28% | +$498K | ﹤0.01% | 1764 |
|
|
2023
Q4 | $1.06M | Buy |
26,642
+1,843
| +7% | +$73.3K | ﹤0.01% | 2295 |
|
|
2023
Q3 | $791K | Sell |
24,799
-2,183
| -8% | -$69.6K | ﹤0.01% | 2424 |
|
|
2023
Q2 | $1.08M | Buy |
26,982
+7,711
| +40% | +$310K | ﹤0.01% | 2320 |
|
|
2023
Q1 | $823K | Buy |
19,271
+1,878
| +11% | +$80.2K | ﹤0.01% | 2433 |
|
|
2022
Q4 | $835K | Buy |
17,393
+7,446
| +75% | +$358K | ﹤0.01% | 2448 |
|
|
2022
Q3 | $374K | Sell |
9,947
-4,268
| -30% | -$160K | ﹤0.01% | 2949 |
|
|
2022
Q2 | $393K | Buy |
14,215
+5,500
| +63% | +$152K | ﹤0.01% | 2977 |
|
|
2022
Q1 | $473K | Buy |
8,715
+896
| +11% | +$48.6K | ﹤0.01% | 3000 |
|
|
2021
Q4 | $458K | Sell |
7,819
-560
| -7% | -$32.8K | ﹤0.01% | 3080 |
|
|
2021
Q3 | $332K | Buy |
8,379
+12
| +0.1% | +$475 | ﹤0.01% | 3218 |
|
|
2021
Q2 | $356K | Buy |
8,367
+2,086
| +33% | +$88.8K | ﹤0.01% | 3195 |
|
|
2021
Q1 | $386K | Sell |
6,281
-8,932
| -59% | -$549K | ﹤0.01% | 3073 |
|
|
2020
Q4 | $1.07M | Buy |
+15,213
| New | +$1.07M | ﹤0.01% | 2531 |
|